VC Mapping Home
Industries
Stages
Countries
Cities
Find investors on Gilion
Industries
AppsAIBiotechFintechSoftwareSaaSMartechLegaltechE-commerce
Countries
DenmarkFinlandFranceGermanySwedenUnited KingdomUnited States
Cities
AmsterdamBerlinBostonCopenhagenLondonLos AngelesMiamiMunichNew YorkParisSan FransiscoSeattleSilicon ValleyStockholm
Investment Stages
Early-StagePre-SeedSeedSeries ASeries B
>
VC Firms
>
New Science Ventures

New Science Ventures

Last updated:

April 25, 2025

2004

Founded

74

Investments

United States

Offices

Venture Fund

Investor Type

About the firm

New Science Ventures (NSV) is a venture capital firm established in 2004, specializing in investments that leverage breakthrough science to create significant value. With over $900 million in assets under management, NSV focuses on companies in the life sciences and information technology sectors that utilize novel scientific approaches to address substantial market needs. The firm operates from its headquarters in Connecticut and maintains an office in London.

Investment Focus

No items found.

Investment Stage

Seed
Series A
Series B
Series C
Series D

HQ Locations

United States
New York

Portfolio Companies

Ventyx Biosciences, Phase Four, Novadip Biosciences, Sagence AI, NorthSea Therapeutics, Vascular Therapies, PlanetiQ, Achronix Semiconductor Corporation, Emporos, InterLink AI

Gepgraphic Focus

United States, United Kingdom

Key Differentiators

Science-Based Innovation, Contrarian Views, Geographic Reach, Team Building, Investment Teams, Patience

Thypical Investment Size

Not publicly disclosed

Total Funds Raised

Over $900 million in assets under management

Visit Website

Website

New York

Seed

Series A

Series B

Series C

Series D

United States